How could inhibiting the reuptake of epinephrine possibly be potent surrounded by the overnight case of clinical anxiety?
SNRI's are commonly prescribed for anxiety disorders. I understand how inhibiting serotonin may be efficacious in light of assorted symptoms, but inhibiting epinephrine/adrenaline? This seems illogical and inappropriate for clinical anxiety, especially surrounded by light of the possible provision of SSRI's or benzos.
I've had a couple people attempt to explain the hypothesized contributory (?) link between symptomology and efficacy, but I still don't get it.
Can anyone provide a scientific explanation of the underlying components of action, here, resulting in alleviation of anxiety-specific sxs?
Answers:
I do not know the exact answer here. Most practitioners I'm aware of shy away from the use of noradrenergic drugs in the treatment of anxiety, and anecdotally they any work very well, or make things much worse. However, the NICE review states that they are influential, though it also has some other boneheaded statements in it.
When we generally infer of epi or nor-epi, we think of their role in the sympathetic nervous system - exchange blows or flight, the adrenaline rush, their vasoconstrictive properties. What's important to realize, is that as monamine transmitters that couple to GPCRs, they are not directly excititory, they are modulatory. Modulatory in the sense that they do not explanation the direct depolarization of a membrane (AP firing or muscle contraction), but instead alter the internal metabolism of the cell, typically through cAMP (in the sympathetic NS)
One of the more recent discoveries is that of a small peptide transmitter called neuropeptide S. NPS, and it's receptor, NPSR, are localized almost exclusively to the locus coeruleus in the brain. This single area contains noradrenergic neurons that project to necessarily every meaningful area of the brain. Now, here's the strange part - activation of NPSR have two significant clinical effects in mouse models - potent anxiolysis on a par with benzodiazepines, and at the same time it promotes strong arousal/alertness. This is a contradiction to the MoA we usually associated with relief of anxiety - sedation.
There are several possibilities here. If I were to menace a guess, I'd say that the LC's termination in the Amygdala is important near regards to norepi's relief of anxiety. One is that, the modulation norepi causes within the receiving neurons is not the same as what happens contained by, say a muscle innervated by the SNS. It could increase the threshold a nerve needs to fire, slowing down stir. Another possibility is that these norepi neuron projections could terminate on inhibitor neurons, say GABAergics, and further down the line motive inhibition.
There's also the possibility that there is a much higher level effect, such as speak altering perception, or information processing. I don't regard this plausible without evidence to back it up - we're dealing beside levels of the brain generally below that level of complexity. It's not impossible, only just not likely given the above more mundane alternatives.
There's probably stuff I should be thinking of and am not, but this is the sort of thing that occurs to me at 1 AM.
the defence of anxiety hasnt been discoverd
but I think it can be effective on restlessness rigidity and dyspnea
but not effective on tachycardia
Related Questions:
Question going on for each day dosage of aspirin!?
Mixed a couple drugs, is it dodgy?
Nurses/Medics - Is this a hypertensive crisis?
I've had a couple people attempt to explain the hypothesized contributory (?) link between symptomology and efficacy, but I still don't get it.
Can anyone provide a scientific explanation of the underlying components of action, here, resulting in alleviation of anxiety-specific sxs?
Answers:
I do not know the exact answer here. Most practitioners I'm aware of shy away from the use of noradrenergic drugs in the treatment of anxiety, and anecdotally they any work very well, or make things much worse. However, the NICE review states that they are influential, though it also has some other boneheaded statements in it.
When we generally infer of epi or nor-epi, we think of their role in the sympathetic nervous system - exchange blows or flight, the adrenaline rush, their vasoconstrictive properties. What's important to realize, is that as monamine transmitters that couple to GPCRs, they are not directly excititory, they are modulatory. Modulatory in the sense that they do not explanation the direct depolarization of a membrane (AP firing or muscle contraction), but instead alter the internal metabolism of the cell, typically through cAMP (in the sympathetic NS)
One of the more recent discoveries is that of a small peptide transmitter called neuropeptide S. NPS, and it's receptor, NPSR, are localized almost exclusively to the locus coeruleus in the brain. This single area contains noradrenergic neurons that project to necessarily every meaningful area of the brain. Now, here's the strange part - activation of NPSR have two significant clinical effects in mouse models - potent anxiolysis on a par with benzodiazepines, and at the same time it promotes strong arousal/alertness. This is a contradiction to the MoA we usually associated with relief of anxiety - sedation.
There are several possibilities here. If I were to menace a guess, I'd say that the LC's termination in the Amygdala is important near regards to norepi's relief of anxiety. One is that, the modulation norepi causes within the receiving neurons is not the same as what happens contained by, say a muscle innervated by the SNS. It could increase the threshold a nerve needs to fire, slowing down stir. Another possibility is that these norepi neuron projections could terminate on inhibitor neurons, say GABAergics, and further down the line motive inhibition.
There's also the possibility that there is a much higher level effect, such as speak altering perception, or information processing. I don't regard this plausible without evidence to back it up - we're dealing beside levels of the brain generally below that level of complexity. It's not impossible, only just not likely given the above more mundane alternatives.
There's probably stuff I should be thinking of and am not, but this is the sort of thing that occurs to me at 1 AM.
the defence of anxiety hasnt been discoverd
but I think it can be effective on restlessness rigidity and dyspnea
but not effective on tachycardia
Related Questions: